The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furn Regulatory News (DFS)

Share Price Information for Dfs Furn (DFS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 114.00
Bid: 114.00
Ask: 115.20
Change: 1.00 (0.88%)
Spread: 1.20 (1.053%)
Open: 114.00
High: 115.60
Low: 114.00
Prev. Close: 113.00
DFS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

17 Jul 2023 07:00

RNS Number : 1365G
DFS Furniture PLC
17 July 2023
 

THIS STATEMENT CONTAINS INSIDE INFORMATION

 

DFS FURNITURE plc

 

PERIOD END TRADING UPDATE

 

FY23 profit within previously guided range

Group achieves record market share

 

 

DFS, ("DFS" and "the Group"), the market leading retailer of living room and upholstered furniture in the United Kingdom, announces the following update for the 52 week period to 25 June 2023 ("FY23").

 

FY23 Highlights:

 

● Record market share of 38%, underpinned by the Group's leading brands, scale and well invested integrated retail proposition

● Underlying profit before tax and brand amortisation for FY23 in line with previous guidance at slightly above £30m despite the market being significantly worse than expected

● Gross margin rate continuing to improve, supported by freight costs returning to pre-pandemic levels and effective cost control

● Consumer demand continues to be impacted by the macroeconomic environment; market volumes down by c.15%-20% across FY23

● Expect to continue to outperform a declining market in FY24 and grow market share delivering low single digit £m profit growth

FY23 trading performance delivered strong market share gains in a weak market

 

The Group has a track record of growing market share in all trading environments. This has continued through FY23, with market share increasing to 38%. Gross sales increased by 15% compared to the comparative* pre pandemic period (FY19), down 4% year on year.

 

The well-publicised global macro-economic challenges impacted overall market volumes, which were down c.15-20% year-on-year. However, an improving gross margin rate and good cost control supported an estimated underlying profit before tax and brand amortisation of just over £30m.

 

Outlook for FY24

 

Trading at the start of the year has been consistent with the Board's expectations. We currently expect market volumes to decline by mid-single digits for the full year, however, the economic outlook remains uncertain. To that end the business has been prudent in its planning, is taking actions to maximise operating cashflow through continuous margin improvement, delivering cost savings and reducing capital expenditure. Despite the ongoing pressure on market volumes, we expect underlying profit in FY24 to be slightly above FY23 levels, supported by the Group's leading brands, scale and well invested integrated retail proposition.

 

Longer term view

 

When the market recovers, given our increased market share, the operating leverage within the business and our negative working capital cycle, we are well positioned and remain confident in delivering our long-term targets of £1.4bn of revenue, an 8% profit before tax margin and 75% post tax free cash conversion driving strong returns for our shareholders.

 

Comment from Tim Stacey, Group Chief Executive

 

"I would like to take this opportunity to thank every one of our colleagues and partners for their commitment, hard work and dedication as we trade through the increasingly challenging market conditions.

 

We are in the strongest position we have ever been as a Group in terms of market share, and when the market recovers, we will be well placed to deliver our strategy and grow our earnings and cash flows towards our longer term plan"

 

The Group will report its FY23 results on 21 September 2023.

 

*Pro forma unaudited 52 week period to 30 June 2019. Excludes International and Sofa Workshop given the closure of these operations.

 

DFS (enquiries via Teneo)

Tim Stacey (Group CEO)

John Fallon (Group CFO)

Phil Hutchinson (Investor Relations)

investor.relations@dfs.co.uk

 

Teneo

James Macey-White

Jessica Reid

Ayo Sangobowale

+44 (0)20 7353 4200

85fs.dfs@teneo.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFERDEISLIV
Date   Source Headline
9th Apr 20247:00 amRNSPost 2023 AGM Shareholder Engagement - Update
8th Apr 20247:00 amRNSHolding(s) in Company
19th Mar 20247:00 amRNSInterim Results
19th Jan 20247:00 amRNSTrading Statement
21st Dec 20233:40 pmRNSHolding(s) in Company
1st Dec 20233:36 pmRNSHolding(s) in Company
15th Nov 202312:36 pmRNSHolding(s) in Company
14th Nov 202312:12 pmRNSHolding(s) in Company
10th Nov 20233:26 pmRNSRESULTS OF AGM
7th Nov 20237:00 amRNSHolding(s) in Company
6th Nov 20237:00 amRNSHolding(s) in Company
20th Oct 202312:14 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSAnnual Financial Report
22nd Sep 202310:13 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSFY23 Preliminary Results
7th Sep 20237:00 amRNS£250M NEW CREDIT FACILITIES SIGNED
17th Jul 20237:00 amRNSTrading Statement
12th Jul 20237:00 amRNSDirector Declaration
9th Jun 20237:00 amRNSDirectorate Change
8th Jun 202310:25 amRNSHolding(s) in Company
3rd May 20239:51 amRNSHolding(s) in Company
21st Apr 20231:54 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim Results
9th Feb 20237:00 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSDirectorate Change
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20237:00 amRNSHolding(s) in Company
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSTransaction in Own Shares
13th Jan 20237:00 amRNSTrading Statement
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20237:00 amRNSTransaction in Own Shares
11th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSTransaction in Own Shares
29th Dec 20222:04 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSTransaction in Own Shares
28th Dec 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.